RAS Targeted Drug Discovery Virtual Meeting
Real-World Data: Importance of Monitoring KRAS Mutations in Blood
Kerstin Pohl from Biodesix will be presenting
September 16 at 10 AM EDT
IASLC's NACLC - October 15-17
CHEST - October 19-20
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
CORPORATE HEADQUARTERS
2970 Wilderness Place, Suite 100
Boulder, CO 80301
Phone (866) 432-5930
Fax (866) 432-3338
© Copyright 2020 Biodesix.
All Rights Reserved.
